Oncimmune (ONC) Insider Trading & Ownership → The World's First '$20 Trillion Drug?' (From Behind the Markets) (Ad) Free ONC Stock Alerts GBX 23.50 -1.00 (-4.08%) (As of 04/25/2024 ET) Add Compare Share Share Insider TradesStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades Oncimmune (LON:ONC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage28.80%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)£19,883.91Number OfInsiders Selling(Last 12 Months)0 Get ONC Insider Trade Alerts Want to know when executives and insiders are buying or selling Oncimmune stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ONC Insider Buying and Selling by Quarter Ad American AlternativeYour Money is Not SafeBiden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…CLICK HERE TO GET YOUR GUIDE NOW Oncimmune Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/8/2023Martin GouldstoneInsiderBuy36,023GBX 27£9,726.216/5/2023Adam HillInsiderBuy48,370GBX 21£10,157.70 (Data available from 1/1/2013 forward) ONC Insider Trading Activity - Frequently Asked Questions Who is on Oncimmune's Insider Roster? The list of insiders at Oncimmune includes Adam Hill, and Martin Gouldstone. Learn more on insiders at ONC. What percentage of Oncimmune stock is owned by insiders? 28.80% of Oncimmune stock is owned by insiders. Learn more on ONC's insider holdings. Which Oncimmune insiders have been buying company stock? The following insiders have purchased ONC shares in the last 24 months: Adam Hill (£15,120.80), and Martin Gouldstone (£9,726.21). How much insider buying is happening at Oncimmune? Insiders have purchased a total of 92,398 ONC shares in the last 24 months for a total of £24,847.01 bought. More Insider Trading Tools from MarketBeat Related Companies: OBD Insider Selling DEST Insider Selling OPTI Insider Selling OKYO Insider Selling SAR Insider Selling BVX Insider Selling ROQ Insider Selling TRX Insider Selling POLB Insider Selling ETX Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (LON:ONC) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmithRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncimmune Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
